Cargando…
Clinical Manifestations, Treatment, and Prevention of Acute Irritant Contact Dermatitis Caused by 2,4-Dichloro-5-Methylpyrimidine
BACKGROUND: There are no reported cases of 2,4-dichloro-5-methylpyrimidine (DCP)–induced irritant contact dermatitis (ICD). OBJECTIVE: The aim of the study was to summarize the clinical features, treatment, and protective measures for DCP-induced ICD. METHODS: We retrospectively reviewed the clinica...
Autores principales: | Fan, Wenge, Zhang, Qingsong, Zhang, Jing, Wang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813440/ https://www.ncbi.nlm.nih.gov/pubmed/31688132 http://dx.doi.org/10.1097/DER.0000000000000540 |
Ejemplares similares
-
Crystal structure of 4,6-dichloro-5-methylpyrimidine
por: Medjani, Meriem, et al.
Publicado: (2015) -
Severe Irritant Contact Dermatitis Causing Skin Ulceration Secondary to a Testosterone Patch
por: Lawrentschuk, Nathan, et al.
Publicado: (2009) -
Facial Irritant Contact Dermatitis Caused by Pyraclostrobin
por: Wang, Qiuyue, et al.
Publicado: (2022) -
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis
por: Bonnekoh, Hanna, et al.
Publicado: (2021) -
Cytokines and Chemokines in Irritant Contact Dermatitis
por: Lee, Haur Yueh, et al.
Publicado: (2013)